Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users
- PMID: 19782540
- PMCID: PMC2925833
- DOI: 10.1016/j.pscychresns.2009.03.011
Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users
Abstract
Methamphetamine (METH) users showed structural and chemical abnormalities on magnetic resonance (MRI) studies, particularly in the frontal and basal ganglia brain regions. Diffusion tensor imaging (DTI) may provide further insights regarding the microstructural changes in METH users. We investigated diffusion tensor measures in frontal white matter and basal ganglia of 30 adult METH users and 30 control subjects using a 3 T MR scanner. Compared with healthy control subjects, METH users showed lower fractional anisotropy (FA) in right frontal white matter, and higher apparent diffusion coefficient (ADC) in left caudate and bilateral putamen. Higher left putamen ADC was associated with earlier initiation of METH use, greater daily amounts, and a higher cumulative lifetime dose. Similarly, higher right putamen ADC was associated with greater daily amounts and a higher cumulative lifetime dose. The lower FA in the right frontal white matter suggests axonal injury in these METH users. The higher ADC in the basal ganglia suggests greater inflammation or less myelination in these brain regions of those with younger age of first METH use and greater METH usage.
Figures
References
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press; Washington, DC: 2000.
-
- Bae SC, Lyoo IK, Sung YH, Yoo J, Chung A, Yoon SJ, Kim DJ, Hwang J, Kim SJ, Renshaw PF. Increased white matter hyperintensities in male methamphetamine abusers. Drug and Alcohol Dependence. 2006;81:83–88. - PubMed
-
- Bhagat YA, Beaulieu C. Diffusion anisotropy in subcortical white matter and cortical gray matter: changes with aging and the role of CSF-suppression. Journal of Magnetic Resonance Imaging. 2004;20:216–227. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K01 DA021203/DA/NIDA NIH HHS/United States
- P20 RR011091/RR/NCRR NIH HHS/United States
- 2 G12 RR003061-21/RR/NCRR NIH HHS/United States
- K02 DA16991-TE/DA/NIDA NIH HHS/United States
- U54 NS039406/NS/NINDS NIH HHS/United States
- P20 RR11091-10/RR/NCRR NIH HHS/United States
- K24-DA16170-LC/DA/NIDA NIH HHS/United States
- K02 DA016991/DA/NIDA NIH HHS/United States
- K24 DA016170/DA/NIDA NIH HHS/United States
- U54-039406-DA/DA/NIDA NIH HHS/United States
- K01-DA021203-CC/CC/CDC HHS/United States
- G12 RR003061/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
